The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
switch off from it. The Directors have done this before, Richard Griffiths has done this before. Both sets of parties have enormous skin in the game. 62.5p within 18 months is my bet...What do I care what last years update is going to say? We know it has no debt after the deal with AZN..so it will survive..Patience is what we need here
very worrying as the price is dropping further doesnt bode well imo
Quite a few directors buys in april
I think it poor investor relations. Normally worrying but buys well outnumbering sells. There is still the usa spat not updated . Has anyone asked when announcement will be made well away fron last year
Somewhat surprised by this.....and worried. A number of companies have delayed results but at the time of announcement all the one's I invest in have given a revised date. Fingers crossed nothing is wrong but as I say surprising they cannot give even an indication of a date.
not soon....from other board
Received an email back from them confirming that no results announcement planned for May
Emailed company a few days ago asking when results would be published as they seem to be overdue. A stunning silence in return. No courtesy of a reply
The Options will vest on the third anniversary of the date of grant and are exercisable until the tenth anniversary of the date of grant. Vesting is subject to either the price of an Ordinary Share reaching 62.4p for at least 30 consecutive dealing days or a liquidity event occurring above this level.
The above quote from recent rns is I think an indication of things to come. The new business should be less cyclical. The above option deal reminds me of similar options at Bioquell- this rocketed a while after grant. I mention this as the finance director hails from Bioquell. Short term, who knows......long term this should reward the patient.
Can this drifting back to the high teens, the delayed results are a worry to me.
Bounced straight up again and more. Vagaries of the market. A well balanced market here.
What’s up here? That was a pretty swift decline into the low 25p zone. People selling in anticipation of poor final results? We were warned that Duaklir sales were naff, although we have now shed our AZN debt which arguably puts us in a strong position. Recent director buys along with increased holdings from the likes of RG still give me confidence. If you believe in charts, the MACD seems to hint that a drop was imminent, so maybe this is it. Wouldn’t surprise me if we saw a large delayed trade later as being the culprit for this price drop.
NAS are a Harwood Capital Investment Trust (they have 3). Another of their Investment Trusts Oryx International Growth has 4.44% CIR disclosed end February.
North Atlantic Smaller Companies investment trust appear to have bought 3.8 million shares
Well the someone was interest enough to do the deal
Looks like today’s RNS confirmed it was a sale from Lombard. Probably just following their risk management strategy and reducing slightly. Nothing I’m too concerned about. Wonder if we’ll find out who bought the stock?
Depending on the timing 26p feels more like a buy price. Represents just under 1% I think. I wonder if there's anyone who'd be interested and able to deal in those volumes.
Large 3.4m trade @ 26p posted as a sale. Seems to have gone through as an ordinary sale, but I’m surprised the liquidity exists to simply hit the sell button on a trade that size.
For what it's worth I have and like gsK. Emma walmsley good on sky news. Very good answered questions including about the proprosed split, still on
Yes your spot on . He isn’t doing anything illegal.its just the way the corrupt system works in my view. Not in at the moment, hoping for a drop back a bit so I can get in lower. I bought and sold AstraZeneca for 7100 for a 300 pound profit . Since then it’s rocketed back up to 7900 . Silly me I should have held.
I’m expecting GSK to start catch up. I hope!
Yes again you are right. But like trump and america first Griffiths is Griffith first. He is doing nothing illegal at lesdt i do not think so
You are quite right. Originally mesnt to be biotech but this did not happen in the event. I dont think it is listed on aim now but i could be wrong
very many apologies. Dreamers was meant to be derampers defeated spell check
Dead right, if he had total number of shares in HIS name over 30% then he would by rule nine (aim) have to make an offer to all shareholders at the highest sp paid over the last twelve months
Anyone in the last twelve months
The company being referred to is Sarossa Plc, and it’s an investment company, not specifically biotech it seems.
RG it seems could be the beneficial owner of nearly 30% of CIR, through various investment vehicles. Does this way of indirectly holding the shares impact whether he’ll have to make an offer, should he cross the 30% threshold.
I’m wondering if he’s planning on gaining control as a means to turn it into a cash shell and RTO a private company. Which one though I have no idea.